4SC AG VSC.F Stock
7.78 EUR
{{ price }}
-7.159904%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
78.69M EUR
LOW - HIGH [24H]
7.76
-
7.78 EUR
VOLUME [24H]
500 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.81 EUR
4SC AG Price Chart
4SC AG VSC.F Financial and Trading Overview
| 4SC AG stock price | 7.78 EUR |
| Previous Close | 12.6 EUR |
| Open | 12.4 EUR |
| Bid | 0 EUR x 165400 |
| Ask | 0 EUR x 161000 |
| Day's Range | 11.2 - 12.4 EUR |
| 52 Week Range | 1.1 - 13.9 EUR |
| Volume | 4.28K EUR |
| Avg. Volume | 3.87K EUR |
| Market Cap | 117.32M EUR |
| Beta (5Y Monthly) | 1.411494 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.81 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.5 EUR |
VSC.F Valuation Measures
| Enterprise Value | 101.49M EUR |
| Trailing P/E | N/A |
| Forward P/E | -23.67347 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 269.08807 |
| Price/Book (mrq) | 8.828007 |
| Enterprise Value/Revenue | 232.766 |
| Enterprise Value/EBITDA | -7.771 |
Trading Information
4SC AG Stock Price History
| Beta (5Y Monthly) | 1.411494 |
| 52-Week Change | 614.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.9 EUR |
| 52 Week Low | 1.1 EUR |
| 50-Day Moving Average | 3.77 EUR |
| 200-Day Moving Average | 2.39 EUR |
VSC.F Share Statistics
| Avg. Volume (3 month) | 3.87K EUR |
| Avg. Daily Volume (10-Days) | 12.58K EUR |
| Shares Outstanding | 10.11M |
| Float | 3M |
| Short Ratio | N/A |
| % Held by Insiders | 71.91% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3137.38% |
| Gross Margin | 64.44% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.67% |
| Return on Equity (ttm) | -70.15% |
Income Statement
| Revenue (ttm) | 436K EUR |
| Revenue Per Share (ttm) | 0.04 EUR |
| Quarterly Revenue Growth (yoy) | 22.00% |
| Gross Profit (ttm) | 281K EUR |
| EBITDA | -13059000 EUR |
| Net Income Avi to Common (ttm) | -14361000 EUR |
| Diluted EPS (ttm) | -3.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.83M EUR |
| Total Cash Per Share (mrq) | 1.47 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.83 |
| Book Value Per Share (mrq) | 1.314 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9383000 EUR |
| Levered Free Cash Flow (ttm) | -9804375 EUR |
Profile of 4SC AG
| Country | Germany |
| State | N/A |
| City | Planegg |
| Address | Fraunhoferstraße 22 |
| ZIP | 82152 |
| Phone | 49 89 700 763 0 |
| Website | https://www.4sc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 15 |
4SC AG, a biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs in Germany. The company's product in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor for the treatment of cutaneous T-cell lymphoma. The company also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company was founded in 1997 and is headquartered in Planegg, Germany.
Q&A For 4SC AG Stock
What is a current VSC.F stock price?
4SC AG VSC.F stock price today per share is 7.78 EUR.
How to purchase 4SC AG stock?
You can buy VSC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 4SC AG?
The stock symbol or ticker of 4SC AG is VSC.F.
Which industry does the 4SC AG company belong to?
The 4SC AG industry is Biotechnology.
How many shares does 4SC AG have in circulation?
The max supply of 4SC AG shares is 10.11M.
What is 4SC AG Price to Earnings Ratio (PE Ratio)?
4SC AG PE Ratio is now.
What was 4SC AG earnings per share over the trailing 12 months (TTM)?
4SC AG EPS is -0.81 EUR over the trailing 12 months.
Which sector does the 4SC AG company belong to?
The 4SC AG sector is Healthcare.
4SC AG VSC.F included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| TECHN. ALL SHARE PR TECALLP | 2938.93 EUR 3212.65 USD |
-0.79
|
— — | 2928.09 EUR 3200.8 USD | 2962.26 EUR 3238.15 USD | — - | — — |
| PRIME ALL SH. TR PRIME | 7374.03 EUR 8060.81 USD |
-0.32
|
— — | 7345.61 EUR 8029.74 USD | 7397.68 EUR 8086.66 USD | — - | — — |
| DAXSEC.PHA.+HEALTHC.PR CXKPX | 1940.27 EUR 2120.98 USD |
-0.82
|
— — | 1940.27 EUR 2120.98 USD | 1940.27 EUR 2120.98 USD | — - | — — |
| TECHN. ALL SHARE TR TECALL | 3957.08 EUR 4325.62 USD |
-0.79
|
— — | 3942.49 EUR 4309.67 USD | 3988.49 EUR 4359.96 USD | — - | — — |
| DAXSEC.PHA.+HEALTHC.TR CXPPX | 3658.27 EUR 3998.98 USD |
-0.82
|
— — | 3641.35 EUR 3980.49 USD | 3688.46 EUR 4031.99 USD | — - | — — |
- {{ link.label }} {{link}}